NCT03671954

Brief Summary

In total knee arthroplasty (TKA), the relationship between implant design, soft tissue balance, neuromuscular contributions, and rehabilitation strategies on patient satisfaction and functional outcomes is highly complex and poorly understood. The investigators will prospectively study the effects of these factors using in vivo assessments preoperatively, and postoperatively. Computer simulation models will also be used to analyze lower extremity biomechanics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 31, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 14, 2018

Completed
8 months until next milestone

Study Start

First participant enrolled

May 1, 2019

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 16, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 16, 2023

Completed
Last Updated

November 30, 2023

Status Verified

November 1, 2023

Enrollment Period

4.5 years

First QC Date

August 31, 2018

Last Update Submit

November 28, 2023

Conditions

Keywords

knee osteoarthritisrehabilitation strategiessoft tissue balance

Outcome Measures

Primary Outcomes (2)

  • Top declined walking speed before and after TKA.

    Top walking speed is defined as the maximum speed a patient feels that they can safely walk without running. Patients will walk on an instrumented treadmill declined at seven degrees.

    Tested preoperatively, and once during the two to four months after TKA

  • Bilateral isometric quadriceps, hamstrings, and gluteus medius strength before and after TKA

    Maximum isometric quadriceps, hamstrings, and gluteus medius strength as measured by a dynamometer.

    Tested preoperatively, and once during the two to four months after TKA

Study Arms (3)

TKA Intervention Group

EXPERIMENTAL

The TKA intervention group will perform unsupervised home strengthening exercises for the hip abductors in addition to standard physical therapy.

Behavioral: Home Strengthening ExercisesOther: Standard Physical Therapy

TKA Control Group

ACTIVE COMPARATOR

The TKA control group will receive standard physical therapy alone.

Other: Standard Physical Therapy

Healthy Control Group

ACTIVE COMPARATOR

The Healthy Control Group, aged 49-85 years without any signs of degenerative joint, disease will undergo the preoperative assessments only.

Other: Preoperative Assessments

Interventions

The intervention group will perform unsupervised home strengthening exercises for the hip abductors in addition to standard physical therapy, while the control group will receive standard physical therapy alone.

Also known as: Hip abductor strengthening program
TKA Intervention Group

Physician determined standard of care for individual TKA patients.

TKA Control GroupTKA Intervention Group

Assessments will include: * TUG (timed up and go test) \>12 sec indicates increased fall risk * Tandem balance test \< 10 sec indicates increased fall risk * Sit to Stand test (age based norms) * Knee Range Of Motion (ROM) * Quadriceps and hamstring strength (MMT or hand held dynamometer) * Lower Extremity Functional Score (LEFS questionnaire)

Healthy Control Group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients requiring unilateral TKA for knee osteoarthritis
  • No osteoarthritis symptoms in contralateral knee
  • Radiographic coronal deformity ≤ 15°
  • Preoperative flexion ≥ 90°
  • Receiving one of four implants used by UF Orthopaedic surgeons
  • Able to walk for a short distance without the use of ambulatory aids
  • Healthy Participants:
  • Age 49-85 years
  • Healthy with no signs or symptoms of lower limb arthritis or injury
  • Able to walk for a short distance without the use of ambulatory aids

You may not qualify if:

  • BMI \> 40 kg/m2
  • Presence of knee, hip, or ankle prosthesis for either limb
  • Presence of hip prosthesis in surgical limb (TKA only subjects)
  • History of lower limb or spinal surgery within the last year
  • Presence of neurologic or orthopaedic disorders that could affect gait or balance
  • Chronic opioid or illicit drug use
  • Poorly controlled diabetes (HbA1C \> 7 percent)
  • Chronic pain syndrome
  • Chronic back pain
  • Presence of vestibular disorder
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

UF & Shands Orthopaedics and Sports Medicine Institute

Gainesville, Florida, 32607, United States

Location

UF Health Florida Surgical Center

Gainesville, Florida, 32607, United States

Location

UF Health at the University of Florida

Gainesville, Florida, 32610, United States

Location

UF Health Cancer Hospital

Gainesville, Florida, 32610, United States

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • MaryBeth Horodyski, EdD

    University of Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Participant, outcome assessor
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The intervention group will perform unsupervised home strengthening exercises for the hip abductors in addition to standard physical therapy, while the control group will receive standard physical therapy alone. Subjects will be assigned to one of two groups by block randomization, such that patients receiving each different implant design comprise each block.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 31, 2018

First Posted

September 14, 2018

Study Start

May 1, 2019

Primary Completion

November 16, 2023

Study Completion

November 16, 2023

Last Updated

November 30, 2023

Record last verified: 2023-11

Locations